COMMUNIQUÉS West-GlobeNewswire

Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
08/09/2026
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (Nasdaq: EPRX) (TSX: EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program
08/09/2026
Company Anticipates $7M-$8M FY’26 Adjusted Gross Profit (1) , vs. Prior Guidance $5M-$7M Company Anticipates Adjusted Net Operating Cash Flow ( 4 ) to Turn Positive in Q3’26 Company Anticipates Generating Positive Core [...]
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery [...]
Collegium to Participate in Upcoming Investor Conferences
08/09/2026
STOUGHTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often [...]
Ibogaine and the Bicameral Mind: The Definitive Clinical and Cultural Guide to Ibogaine Publishes Today
08/09/2026
Ambio Life Sciences CEO Jonathan Dickinson draws on 17 years of clinical practice and Bwiti initiation to bridge tradition and modern neuroscience Foreword by former Texas Governor Rick Perry; praise from Rick Doblin ( [...]
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
Avalyn to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
MIMEDX to Participate in Upcoming Investor Conferences
08/09/2026
MARIETTA, Ga., Sept. 08, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor [...]
Anavex Life Sciences to Host Investor Call on Wednesday, September 9, 2026, at 4:00 PM ET
08/09/2026
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central [...]
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
08/09/2026
Amwell platform expected to facilitate connected care, improving access and quality of care for the more than nine million Veteran beneficiaries BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a [...]
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders [...]
CPTx appoints Matt Kane as Chief Financial Officer
08/09/2026
Experienced gene editing and cell therapy pioneer to head financing and strengthen strategic leadership for CPTx non-viral DNA-based in vivo CAR T platform Munich, Germany & San Francisco, California – September 8, [...]
Renexxion to Present at H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
LOS ALTOS, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Renexxion, Inc. (“Renexxion”), a late-stage clinical biopharmaceutical company building leadership in the development of treatments for GI motility disorders, [...]
Dr. Gillian Cannon Joins Lindus Therapeutics’ Board as a Non-Executive Director
08/09/2026
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lindus Therapeutics , a next-generation drug development company advancing a portfolio of in-licensed assets, has announced the appointment of Dr. Gillian Cannon to its board [...]
GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars
08/09/2026
New whole blood RNA sequencing data identified coordinated, consistent change in genes governing immune re-balancing, myofibroblast inhibition, fibrolysis, basement membrane repair, re-epithelialization, antitussive [...]
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
08/09/2026
--New positive preclinical studies show that sabizabulin can overcome drug resistance to daraxonrasib with potent anticancer efficacy (IC50=18.2nM) in daraxonrasib resistant human pancreatic cancer cell line which is a [...]
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
08/09/2026
RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th Annual Global [...]
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
08/09/2026
Dr. Soon-Shiong will Join PDS Biotech’s Board of Directors PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology [...]

Pages